Ann-Kathrin Schäfer

6PUBLICATIONS
6CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Respiratory diseasesMajor global burdens of diseasePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 18, 2026
Differences in Office and Ambulatory Pulse Wave Analysis in Patients with White Coat Hypertension and Other Hypertension Phenotypes.

|Nov 27, 2024
Urinary Dickkopf-3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart Failure.

Dennis Pieper, Anja Sandek, Ann-Kathrin Schäfer

|Jul 06, 2024
Effects of baroreflex activation therapy on cardiac function and morphology.

Ann-Kathrin C Schäfer, Manuel Wallbach, Charlotte Schroer

|Feb 11, 2023
Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant Hypertension.

Ann-Kathrin C Schäfer, Dennis Pieper, Hassan Dihazi

|Jul 23, 2022
Impact of medication adherence on the efficacy of Baroreflex activation therapy.

Ann-Kathrin C Schäfer, Dieter Müller, Ellen Born

|Jun 08, 2021
Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension.

Ann-Kathrin Schäfer, Tim Kuczera, Rebecca Wurm-Kuczera

Pageof 1

Frequent Collaborators

2 joint publications

Hassan Dihazi

2 joint publications

Gry Helene Dihazi

2 joint publications

Manuel Wallbach

1 joint publications

Andreas Leha